Literature DB >> 2435570

Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.

D R Tomlinson, G B Willars, E F Calthrop-Owen.   

Abstract

This study examined the effect of experimental diabetes on the anterograde and retrograde axonal transport of phosphofructokinase activity. Rats with streptozotocin-induced diabetes of 4 weeks duration showed phosphofructokinase activity accumulation deficits both proximal (53% and 65% in two separate experiments) and distal (80% and 70%) to 24-h sciatic nerve constrictions. There was no significant effect of diabetes on the phosphofructokinase activity per unit length in unconstricted sciatic nerve. Treatment of a group of diabetic rats with the aldose reductase inhibitor, sorbinil, profoundly reduced the concentrations of polyol pathway metabolites (sorbitol and fructose) in sciatic nerve. This effective inhibition of aldose reductase did not alter the accumulation deficits of phosphofructokinase activity on either side of sciatic nerve constrictions. We conclude that short-term experimental diabetes causes impaired axonal transport of phosphofructokinase activity by mechanisms unrelated to aldose reductase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2435570     DOI: 10.1016/0014-4886(87)90180-4

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  2 in total

1.  Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.

Authors:  D R Tomlinson; J P Robinson; A M Compton; P Keen
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

2.  Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.

Authors:  C Pekiner; W G McLean
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.